UMB Conducts First-of-a-Kind Study on Bioequivalency of Anti-Epileptic Drug
August 14, 2015
Collaborative study helps validate effectiveness of FDA’s bioequivalence standard, showing no significant differences between major brand name and generic medication used to treat patients with epilepsy.